Lecture

Choosing a Viral Vector and Delivery Method

Description

This lecture covers the selection of viral vectors for gene therapy, focusing on factors such as genomic integration, cell types transduced, transcript length, vector design, viral genome, and immune reactions. Specific examples are provided, including the use of adeno-associated virus (AAV) vectors for spinal muscular atrophy type 1 (SMA1) therapy and different routes of administration for AAV vectors in the central nervous system.

About this result
This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.